The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Clinical trial NCT01923428 · COMPLETED
Trial details
- NCT number
- NCT01923428
- Sponsor
- Ardelyx
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2014-10-01
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.